Mahzi Therapeutics
CA - San MateoBiotechnology
Focus: Mahzi Therapeutics is a gene therapy biotech focused on rare genetic neurodevelopmental disorders, operating from San Mateo, CA with an early-stage, pre-revenue profile.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Mahzi Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Mahzi Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MZ-1866
Pitt Hopkins SyndromeClinical Trials (1)
NCT07135050Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Phase 1/2Help build intelligence for Mahzi Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.